Clinical Trials

Showing trials with last updates posted in 2017.

NCT01319539 | TERMINATED | PHASE2
12 participants

MK2206 in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2017-08-30
Start Date:
2011-04-30
Completion:
2013-07-31
Conditions
  • Estrogen Receptor Negative
  • Estrogen Receptor Positive
  • HER2/Neu Negative
  • HER2/Neu Positive
  • Progesterone Receptor Negative
  • Progesterone Receptor Positive
  • Stage IA Breast Cancer
  • Stage IB Breast Cancer
  • Stage IIA Breast Cancer
  • Stage IIB Breast Cancer
  • Stage IIIA Breast Cancer
  • Stage IIIB Breast Cancer
  • Stage IIIC Breast Cancer
  • Triple-Negative Breast Carcinoma
Interventions
  • DRUG
  • PROCEDURE
  • OTHER
NCT00988715 | COMPLETED | PHASE1
17 participants

Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome

Study Type:
INTERVENTIONAL
Last Updated:
2017-08-30
Start Date:
2010-04-21
Completion:
2015-01-31
Conditions
  • Chronic Myelomonocytic Leukemia
  • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
  • Previously Treated Myelodysplastic Syndrome
  • Recurrent Adult Acute Lymphoblastic Leukemia
  • Recurrent Adult Acute Myeloid Leukemia
  • Refractory Anemia With Excess Blasts
  • Refractory Cytopenia With Multilineage Dysplasia
  • Refractory Cytopenia With Multilineage Dysplasia and Ringed Sideroblasts
  • Secondary Acute Myeloid Leukemia
Interventions
  • BIOLOGICAL
  • DRUG
  • RADIATION
  • PROCEDURE
  • OTHER
No Results Yet
NCT00522002 | COMPLETED
40 participants

CLUE Study: Connective Tissue Disease Leg Ulcer Etiology Study

Study Type:
OBSERVATIONAL
Last Updated:
2017-08-30
Start Date:
2007-08-31
Completion:
2010-06-30
Conditions
  • Connective Tissue Diseases
  • Blood Coagulation Disorders
  • Leg Ulcers
  • Rheumatoid Arthritis
  • Systemic Lupus Erythematosus
  • Systemic Scleroderma
  • Mixed Connective Tissue Disease
No Results Yet
NCT00005940 | COMPLETED | PHASE2
18 participants

Radiolabeled BC8 Antibody, Busulfan, Cyclophosphamide Followed by Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia in First Remission

Study Type:
INTERVENTIONAL
Last Updated:
2017-08-30
Start Date:
1999-10-31
Completion:
2006-01-31
Conditions
  • Adult Acute Myeloid Leukemia in Remission
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • Adult Acute Myeloid Leukemia With Del(5q)
  • Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)
  • Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)
  • Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)
  • Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)
Interventions
  • RADIATION
  • DRUG
  • PROCEDURE
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page